DK2268669T3 - Bovine colostrum containing antibodies to insulin for the treatment of metabolic disorders - Google Patents

Bovine colostrum containing antibodies to insulin for the treatment of metabolic disorders

Info

Publication number: DK2268669T3
Authority: DK; Denmark
Prior art keywords: insulin; treatment; metabolic disorders; containing antibodies; bovine colostrum
Prior art date: 2008-03-13

Application number

DK09720973.8T

Other languages

Danish (da)

Inventor

Yaron Ilan

Gad Lalazar

Ami Ben-Yaakov

Tomer Adar

Original Assignee

Immuron Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-13

Filing date

2009-03-11

Publication date

2017-11-20

2009-03-11 Application filed by Immuron Ltd filed Critical Immuron Ltd

2017-11-20 Application granted granted Critical

2017-11-20 Publication of DK2268669T3 publication Critical patent/DK2268669T3/en

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
241000283690 Bos taurus Species 0.000 title 1
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
210000003022 colostrum Anatomy 0.000 title 1
235000021277 colostrum Nutrition 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
208000030159 metabolic disease Diseases 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK09720973.8T 2008-03-13 2009-03-11 Bovine colostrum containing antibodies to insulin for the treatment of metabolic disorders DK2268669T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3622708P	2008-03-13	2008-03-13
PCT/IL2009/000273 WO2009113065A1 (en)	2008-03-13	2009-03-11	Immuno-modulating compositions for the treatment of immune-mediated disorders

Publications (1)

Publication Number	Publication Date
DK2268669T3 true DK2268669T3 (en)	2017-11-20

Family

ID=40875006

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK09720973.8T DK2268669T3 (en)	2008-03-13	2009-03-11	Bovine colostrum containing antibodies to insulin for the treatment of metabolic disorders

Country Status (7)

Country	Link
US (2)	US20110200610A1 (en)
EP (2)	EP2268669B1 (en)
AU (1)	AU2009222965B2 (en)
CA (1)	CA2718381A1 (en)
DK (1)	DK2268669T3 (en)
NZ (1)	NZ587901A (en)
WO (1)	WO2009113065A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2684696T3 (en)	2009-04-27	2018-10-04	Immuron Limited	Preparation of immunoglobulin enriched with anti-LPS for use in the treatment and / or prophylaxis of non-alcoholic steatohepatitis
AU2011290478B2 (en)	2010-08-17	2014-11-13	Hadasit Medical Research Services & Development Limited	Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
PH12013501040A1 (en)	2010-11-23	2022-10-24	Pantheryx Inc	Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
IT1405998B1 (en) *	2010-12-09	2014-02-06	Bionest Ltd	MULTIPURPOSE GEL AGAINST THE VAGINAL DRYNESS WITH A DIRECT AND DELAYED EFFECT
DE102011006809A1 (en)	2011-04-05	2012-10-11	Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg	Use of an agent of antibodies and / or insulin-like growth factor antagonists
US8926980B2 (en) *	2011-07-11	2015-01-06	Camas Incorporated	Compositions against bacterial toxins
ITMI20112435A1 (en) *	2011-12-30	2013-07-01	Bionest Ltd	PROPHYLAXIS AND THERAPY OF AUTOIMMUNE DISEASES WITH CYTOKINES AND GROWTH, ANTIBACTERIAL AND ANTIBODY FACTORS, ISOLATED BY FABRICS AND BIOLOGICAL MAMMALIAN LIQUIDS
AU2013204801B2 (en)	2012-05-23	2014-11-06	Omniblend Innovation Pty Ltd	Composition and method for management of diabetes or pre-diabetes
WO2015063693A1 (en) *	2013-10-30	2015-05-07	Hadasit Medical Research Services And Development Limited	Anti-lps enriched immunoglobulin for use in treatment and/or prophylaxis of fibrosis
BR112017018518A2 (en) *	2015-04-17	2018-04-24	Ignova Gmbh	predicted biomarkers of clinical response for the treatment of antilps immunoglobulin
US20190134096A1 (en) *	2016-05-06	2019-05-09	Hadasit Medical Research Services & Development Limited	Hyperimmune colostrum in the modulation and treatment of conditions associated with the mammalian microbiome
EP3713590B1 (en) *	2017-11-24	2025-05-07	Defensin Therapeutics ApS	Human beta 2 defensin for use in the prevention and treatment of graft-versus-host-disease
CN109010367A (en) *	2018-08-21	2018-12-18	姜伟	Bovine colostrum and preparation method thereof, preparation and the application in preparation tumor
MX2021010118A (en)	2019-02-22	2021-11-12	Aquero Canada Ltd	Fortified milk compositions and their processes of preparation.
US12263192B2 (en)	2019-02-26	2025-04-01	Pantheryx, Inc.	Compositions for management of disorders of the gastrointestinal tract
US20220256873A1 (en) *	2019-07-09	2022-08-18	Aquero Canada Ltd.	Compositions, processes of production, sterilization, and health-promoting uses of lyophilized milk
WO2022103871A1 (en) *	2020-11-10	2022-05-19	Wyomingv Immune, Inc.	Therapeutic compositions for the treatment of covid-19

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1572220A (en) *	1976-10-07	1980-07-30	Mochida Pharm Co Ltd	Immunochemical process of measuring physiologically active substances
US5980896A (en)	1989-06-30	1999-11-09	Bristol-Myers Squibb Company	Antibodies reactive with human carcinomas
JP2879947B2 (en) *	1990-06-04	1999-04-05	鐘紡株式会社	Hair modifier
US5369009A (en) *	1992-04-17	1994-11-29	Dana Farber Cancer Institute	Antibodies for P-glycoprotein encoded by the mdr1 gene and uses thereof
EP0725789B1 (en)	1993-09-20	2003-03-19	Anadis Ltd.	Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
US6436401B1 (en) *	1999-09-14	2002-08-20	Milkhaus Laboratory, Inc.	Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies
AU3250401A (en) *	2000-05-19	2001-11-26	Sergey Georgievich Morozov	Pharmaceuticals for depressing autoimmune disorders by idiotype binding fragments of anti-idiotypic antibodies
CA2437099A1 (en) *	2001-01-30	2002-10-10	The Lauridsen Group, Incorporated	Methods and compositions for treatment of immune dysfunction disorders
KR20040106298A (en)	2002-03-21	2004-12-17	아나디스 리미티드	Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
IL165300A0 (en)	2002-05-21	2005-12-18	Anadis Ltd	Method of prophylaxis of infection
AU2003901008A0 (en)	2003-03-04	2003-03-20	Anadis Ltd	Composition for the treatment and prevention of bacterial infections
WO2005048935A2 (en) *	2003-11-14	2005-06-02	Brigham And Women's Hospital, Inc.	Methods of modulating immunity
KR20070109985A (en)	2004-11-22	2007-11-15	아나디스 리미티드	Bioactive Composition
US8071101B2 (en) *	2005-11-03	2011-12-06	Avaxia Biologics, Inc.	Antibody therapy for treatment of diseases associated with gluten intolerance

2009
- 2009-03-11 WO PCT/IL2009/000273 patent/WO2009113065A1/en not_active Ceased
- 2009-03-11 EP EP09720973.8A patent/EP2268669B1/en not_active Not-in-force
- 2009-03-11 EP EP17172590.6A patent/EP3231816A1/en not_active Withdrawn
- 2009-03-11 AU AU2009222965A patent/AU2009222965B2/en not_active Ceased
- 2009-03-11 CA CA2718381A patent/CA2718381A1/en not_active Abandoned
- 2009-03-11 DK DK09720973.8T patent/DK2268669T3/en active
- 2009-03-11 NZ NZ587901A patent/NZ587901A/en unknown
2010
- 2010-09-10 US US12/879,129 patent/US20110200610A1/en not_active Abandoned
2012
- 2012-12-14 US US13/715,371 patent/US20130164302A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2009222965B2 (en)	2014-10-02
US20110200610A1 (en)	2011-08-18
AU2009222965A1 (en)	2009-09-17
EP2268669A1 (en)	2011-01-05
EP3231816A1 (en)	2017-10-18
CA2718381A1 (en)	2009-09-17
EP2268669B1 (en)	2017-10-18
NZ587901A (en)	2012-11-30
WO2009113065A1 (en)	2009-09-17
US20130164302A1 (en)	2013-06-27

Publication	Publication Date	Title
DK2268669T3 (en)	2017-11-20	Bovine colostrum containing antibodies to insulin for the treatment of metabolic disorders
DK3321276T3 (en)	2021-10-25	Fusion proteins for the treatment of metabolic disorders
LTPA2016005I1 (en)	2018-11-12	Methods of administering anti-il-5 antibodies
DK2114386T3 (en)	2013-03-18	Pharmaceutical composition for the treatment of diabetes complications
DK2269063T3 (en)	2013-12-02	PREDICTION OF RISK OF MAJOR ADVERSE HEART EVENTS
DK2643018T3 (en)	2021-01-18	ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS
DK2776469T3 (en)	2019-07-29	ANTIBODY MOLECULES WITH SPECIFICITY FOR HUMAN OX40
PL2621923T3 (en)	2017-08-31	N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
DK2637690T3 (en)	2017-01-02	Liquid high concentration ANTI-TNF alpha antibody formulations
IL228030B (en)	2018-01-31	Compounds for the treatment of gout and gout-related metabolic disorders
DK2504005T3 (en)	2014-01-13	USE OF 1,3-DIPHENYLPROP-2-ONE-1-DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES
IL229582B (en)	2020-06-30	Antibodies against kir for the treatment of inflammatory disorders
EA201400579A1 (en)	2014-10-30	ANTIBODIES TO IL-36R
BRPI0921022A2 (en)	2015-12-29	pirfenidone treatment for patients with atypical liver function
DK3878859T5 (en)	2024-06-10	Novel oxyntomodulin derivatives and pharmaceutical composition for the treatment of obesity comprising these
DK2177536T3 (en)	2014-07-14	Antibodies to amyloid beta peptide
PL2704734T3 (en)	2015-10-30	Composition useful for the treatment of disorders of lipid metabolism
DK2451482T3 (en)	2019-07-22	COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
DK2585088T3 (en)	2014-08-25	COMPOSITION FOR IMPROVING SEXUAL HEALTH
DK2734212T3 (en)	2017-11-06	Compositions comprising diclofenac for the treatment of postoperative pain
PL2707015T5 (en)	2023-03-13	Lixisenatide as adjunct therapy to basal insulin in type 2 diabetes
DK3005986T3 (en)	2021-11-22	INFUSION OF MEDICINES
EE201300007A (en)	2013-08-15	Combined pharmaceutical composition for the treatment of diabetes and metabolic disorders
DK2117525T3 (en)	2014-02-03	Use of 1-phenyl-3-dimethylamino-propane compounds for the treatment of neuropathic pain
DK2552963T3 (en)	2014-04-07	Humanized antibodies to CXCR4 for the treatment of cancer